Wells Fargo & Company Biomerica Inc Transaction History

Wells Fargo & Company

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.42 - $0.86 $16 - $34	-40 Reduced 0.6%	6,580 $2,000
Q1 2024 May 10, 2024	BUY	$0.82 - $1.29 $1 - $2	2 Added 0.03%	6,620 $5,000
Q4 2023 Feb 09, 2024	BUY	$0.71 - $1.65 $4 - $9	6 Added 0.09%	6,618 $8,000
Q3 2023 Nov 13, 2023	BUY	$0.82 - $1.65 $8 - $16	10 Added 0.15%	6,612 $5,000
Q2 2023 Aug 15, 2023	BUY	$1.12 - $1.87 $26 - $44	24 Added 0.36%	6,602 $8,000
Q1 2023 May 12, 2023	BUY	$1.86 - $3.56 $1 - $3	1 Added 0.02%	6,578 $12,000
Q4 2022 Feb 13, 2023	BUY	$2.98 - $4.17 $14 - $20	5 Added 0.08%	6,577 $22,000
Q3 2022 Nov 14, 2022	BUY	$2.61 - $3.98 $2 - $3	1 Added 0.02%	6,572 $26,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $4.69 $13 - $23	5 Added 0.08%	6,571 $19,000
Q1 2022 May 16, 2022	BUY	$3.59 - $4.64 $7 - $9	2 Added 0.03%	6,566 $29,000
Q4 2021 Feb 14, 2022	BUY	$3.89 - $6.71 $3 - $6	1 Added 0.02%	6,564 $25,000
Q3 2021 Nov 15, 2021	SELL	$3.54 - $5.13 $6,853 - $9,931	-1,936 Reduced 22.78%	6,563 $29,000
Q2 2021 Aug 16, 2021	BUY	$3.41 - $5.9 $6 - $11	2 Added 0.02%	8,499 $34,000
Q1 2021 May 13, 2021	SELL	$5.06 - $8.0 $5,060 - $8,000	-1,000 Reduced 10.53%	8,497 $46,000
Q4 2020 Feb 09, 2021	SELL	$4.71 - $7.85 $76,424 - $127,374	-16,226 Reduced 63.08%	9,497 $47,000
Q3 2020 Nov 05, 2020	BUY	$5.86 - $12.04 $19,660 - $40,394	3,355 Added 15.0%	25,723 $178,000
Q2 2020 Aug 13, 2020	BUY	$5.17 - $8.95 $74,541 - $129,041	14,418 Added 181.36%	22,368 $163,000
Q1 2020 May 14, 2020	BUY	$2.37 - $16.0 $18,841 - $127,200	7,950 New	7,950 $56,000

1.79M

53.7K

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $3.76M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.